RENAISSANCE TECHNOLOGIES LLC

Position in BRNS — Barinthus Biotherapeutics plc.

CIK 1037389 NEW YORK, NY

Position in BRNS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$16,500

-$69,419 QoQ

Shares Held

25,000

-83.4% QoQ

Ownership

0.061%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#11

of 15 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. BRNS ranks #303 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,500	25,000	-83.4%	Shares	Sole	2026-08-13
2026-03-31	$85,919	151,000	+5.5%	Shares	Sole	2026-05-14
2025-12-31	$100,170	143,100	+115.8%	Shares	Sole	2026-02-12
2025-09-30	$82,875	66,300	+82.6%	Shares	Sole	2025-11-13
2025-06-30	$33,759	36,300	+1.7%	Shares	Sole	2025-08-13
2025-03-31	$34,736	35,700	+1.7%	Shares	Sole	2025-05-14
2024-12-31	$42,400	35,100	+25.8%	Shares	Sole	2025-02-13
2024-09-30	$33,201	27,900	+11.2%	Shares	Sole	2024-11-13
2024-06-30	$35,140	25,100	-9.4%	Shares	Sole	2024-08-09
2024-03-31	$65,926	27,700	-6.7%	Shares	Sole	2024-05-13
2023-12-31	$109,589	29,699	+38.8%	Shares	Sole	2024-02-13
2023-09-30	$66,126	21,400	-37.1%	Shares	Sole	2023-11-14
2023-06-30	$70,040	34,000	+198.2%	Shares	Sole	2023-08-11
2023-03-31	$25,536	11,400	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.